Agentic AI for clinical trial sales

Build an agent-first sales organisation for clinical research.

August gives clinical-trial sales teams specialised AI agents that continuously assemble market, account and commercial context and turn it into action.

Less time in systems, more time with people.

FOUNDING DEPLOYMENT PROGRAMME NOW OPEN →
AUGUST · TODAY Friday 28 August · 08:12
Good morning, Alex.

Every morning, your territory has moved overnight.

Two signals for your attention.

External signal
Phase III programme registered at Meridian Bio.
CT.gov
Internal signal
Escalation raised on Meridian Bio's live study.
Helpdesk
August adds context
Meridian Bio's platform renewal is due in Q1. Resolving this escalation is your renewal conversation.
CRMHelpdesk
August recommends
Step in today. A note to their study lead is drafted for your review.
  • Meeting brief ready: Meridian Bio, 10:30
  • Account history, one page
  • Trial activity since you last spoke
  • Prior commitments, theirs and yours
  • Who is new in the room, and likely priorities

You sell.
August carries the context.

August assembles and adds context. You deploy it with judgement.
Platform

Enterprise-grade agentic AI, designed to drive outcomes.

CONTEXT → INTELLIGENCE → AGENTS → ACTION → MEMORY

Connect

CRM, email, meetings, documents, external intelligence. August sits over your stack; it does not replace it.

Understand

A continuously updated commercial context: the assembled picture no individual has time to build.

Reason

Specialised agents interpret that context through clinical-trials knowledge and your own playbooks.

Act

Research, prepare, recommend, draft, monitor. A person decides anything that reaches a customer.

Learn

Commercial memory compounds across your team instead of leaving with a transcript or a departing seller.

Outcomes

The commercial outcomes that matter.

More time with customers

Less searching, summarising, administration and preparation.

Better-prepared conversations

Every interaction starts from the context the seller should have had all along.

Earlier opportunity detection

Signals become commercial action instead of unread information.

Fewer dropped balls

Commitments, risks and next steps stop depending on human memory.

Compounding team knowledge

What your best sellers know becomes available to everyone, and it survives attrition.

Consistent, visible AI adoption

One standard and one measure, instead of every seller improvising alone.

We start every deployment with an agreed baseline. We partner with you to define the commercial outcomes that matter, then measure them on an ongoing basis.

Talk to us

Why August

Deep context, implemented to an enterprise standard.

Clinical research is a complex industry, and its best sellers are domain experts. For a seller to stand out, their agents need the same depth. August reads three layers of context together, and implements its agents to an enterprise standard: permissioned, evidenced and human-controlled.

  • The industry. Registries, regulatory events, pipelines, funding, leadership moves.
  • Your business. Offerings, positioning, playbooks, your competitive picture.
  • The territory. Accounts, CRM, email, calls, relationships, commitments.

SIGNAL → RECOMMENDATION → ACTION

THE INDUSTRYYOUR BUSINESSTHETERRITORYREAD TOGETHER BY AUGUST
See August work

Three workflows that boost your team’s productivity.

Find the signal

"What changed in my territory overnight, and where should I act?"

AUGUST · SIGNALS3 new
BUYING WINDOWTODAY
Meridian Bio: Phase III registered
The capital-intensive stage begins, and a new Head of Clinical Operations joined in June. Draft outreach prepared in your approved voice.
CT.gov #4471Press 08/26
Review draftSnooze

Prepare for the meeting

"Everything I should know before walking into the room."

AUGUST · BRIEF10:30 · Meridian Bio
  • Account history, condensed to one page
  • Trial activity: two changes since last call
  • Open commitments: one of yours is due
  • New in the room: Director, Data Management
  • Likely priorities, with sources attached

Move the opportunity

"What is stalled, what is missing, what should happen next?"

AUGUST · PIPELINE1 needs attention
Meridian Bio: Platform renewalRENEWAL · Q1
Escalation raised on their live study this week · renewal conversation due next quarter.
EXPLORE ALL AUGUST WORKFLOWS →
The shift

Selling is moving from AI-assisted to agent-first.

Sales teams have accumulated CRM, intelligence, enablement, conversation and forecasting systems. Deployed correctly, agentic AI turns that stack from work the seller does into work done for the seller, and each system starts adding to the seller's productivity rather than asking more of it. That is an operating-model change, and it is the work we do with our customers.

Today's sales organisation

  • Sellers search for context
  • Sellers monitor accounts
  • Sellers prepare for meetings
  • Sellers remember commitments
  • Sellers update systems
  • Best practice lives in people's heads
  • AI depends on individual prompting skill

Agent-first sales organisation

  • Context finds the seller
  • Agents monitor accounts continuously
  • Meetings arrive prepared
  • Commitments are tracked automatically
  • Systems update around the seller
  • Best practice becomes organisational intelligence
  • AI is embedded into the operating model
Founding deployments

Build the agent-first sales organisation with us.

We are working with a small number of clinical-trial commercial teams on founding deployments. Bring us the work your sellers should not still be doing by hand.

1

Choose a workflow

One high-value job with a measurable cost today.

2

Configure August

Around your commercial context: data, playbooks, process, controls.

3

Deploy with a defined group

A named team, in a controlled environment.

4

Measure what changed

Against a baseline agreed before go-live.

Your sellers should not have to become AI experts. They should get to be better sellers.

People buy from people. In a small industry where everyone knows everyone, that will matter more in five years, not less. August makes the agent-first shift real for clinical research.

Talk to us
HOME / USE CASES

Workflows currently available within August.

Each is configured to your organisational context, and we are open to the workflows you bring us.

Find the signal

"What changed in my territory overnight, and where should I act?"

AUGUST · SIGNALS3 new
BUYING WINDOWTODAY
Meridian Bio: Phase III registered
The capital-intensive stage begins, and a new Head of Clinical Operations joined in June. Draft outreach prepared in your approved voice.
CT.gov #4471Press 08/26
Review draftSnooze

Prepare for the meeting

"Everything I should know before walking into the room."

AUGUST · BRIEF10:30 · Meridian Bio
  • Account history, condensed to one page
  • Trial activity: two changes since last call
  • Open commitments: one of yours is due
  • New in the room: Director, Data Management
  • Likely priorities, with sources attached

Move the opportunity

"What is stalled, what is missing, what should happen next?"

AUGUST · PIPELINE1 needs attention
Meridian Bio: Platform renewalRENEWAL · Q1
Escalation raised on their live study this week · renewal conversation due next quarter.

Know the account

"The full picture, before I even ask."

AUGUST · ACCOUNTMeridian Bio
ACCOUNT PICTURELIVE
Meridian Bio
3 active studies · 2 open opportunities · renewal due Q1 · last touch 12 Aug (QBR) · new Director of Data Management since June.
CRMEmailIndustry news

Remember everything

"Nothing promised in a meeting gets lost."

AUGUST · MEMORYcaptured today
  • Committed: revised SOW to them by Friday
  • Objection raised: integration timeline
  • Preference noted: quarterly invoicing
  • Next step: technical review, w/c 14 Sep

Customer voice

"What are our customers telling us, as a whole?"

AUGUST · VOICEthis quarter
THEMERISING
Onboarding time
Raised across six accounts this quarter. Turned into a team-level trend with the evidence behind it, so the organisation can learn and act.
CallsTickets

TALK TO US ABOUT YOUR WORKFLOWS →

HOME / EVIDENCE

Independent evidence

Independent research, not August performance claims — yet.

Independent research · Not August performance claims — yet

Sellers who partner with AI are 3.7× more likely to meet quota.

Gartner surveyed 1,026 B2B sellers (January to March 2024) on the competencies that predict success. Effective partnership with AI tools topped the list, ahead of tactical flexibility and mentalising.

Gartner Sales Survey, published 2024 — gartner.com

AI-enabled next best actions: 2.6× more likely to grow.

Sales organisations that give sellers AI-enabled next best actions are 2.6 times more likely to achieve commercial growth, from a Gartner survey of chief sales officers conducted in late 2025. Gartner also forecasts that by 2027, 95% of sellers’ research workflows will begin with AI.

Gartner, 2026 — gartner.com

AI can double the time sellers spend selling.

Bain finds sellers spend only around a quarter of their time actually selling, and that AI applied across the sales cycle can roughly double it, with win-rate improvements of more than 30% available to teams that deploy it properly.

Bain & Company, Technology Report 2025 — bain.com

Sellers expect agents to cut research time by a third.

Salesforce’s survey of 4,050 sales professionals (late 2025) found the average seller spends about 40% of their time selling. 54% have used AI agents, nearly nine in ten plan to by 2027, and sellers expect agents to cut prospect research time by 34% and drafting by 36%.

Salesforce, State of Sales 2026 — salesforce.com

People with AI do materially better knowledge work.

In a field experiment with 758 BCG consultants, those using AI on tasks within its capability worked 25.1% faster, with quality rated over 40% higher. They did worse when trusting AI beyond its capability; domain context is the difference.

Dell’Acqua et al., Organization Science (2025) — ssrn.com

The benefit depends on organisational deployment.

Microsoft’s 2026 Work Trend Index found that only 19% of AI users work where individual capability and organisational readiness reinforce each other. The constraint is the operating model, not the technology.

Microsoft Work Trend Index, 2026 — microsoft.com/worklab
HOME / ABOUT

Clinical trials × enterprise sales × agentic AI.

Every system a seller touches was built for someone else: the CRM for management visibility, the forecasting tool for the CFO. August is built from the seller's side of the desk.

Founder · Commercial

Jatin (J) Jain

Eighteen years selling clinical trial technology to pharma, biotech and CROs, from randomisation systems in the 2000s to enterprise eClinical platforms, most recently as a sales leader at one of the industry's largest SaaS providers.

LINKEDIN →
Engineering

Enterprise systems

Led by an engineering partner with two decades designing, building and operating production platforms inside large enterprises, where security review, uptime and audit are conditions of doing business.

AI & Product

Commercial AI practice

Advised by leadership that has built and run AI-driven sales and marketing programmes for global enterprise clients, bringing tested agent patterns from other industries into clinical research.

We have lived this problem from both sides: the complexity of enterprise clinical-trial selling, and the difficulty of turning general-purpose AI into something sellers actually use.

HOME / TALK TO US

Tell us about your commercial bottleneck.

We may come back with questions, and occasionally with a working agentic workflow for you to test on your exact bottleneck.

HOME / PRIVACY

Privacy notice

Plain language, deliberately. This notice covers this website only; customer deployments are governed by separate written agreements.

LAST UPDATED · 28 AUGUST 2026

Who we are

This website is operated by August Clinical ("August", "we"). You can reach us at hello@augustclinical.ai.

What we collect

When you contact us through this site, we collect what you choose to give us: your name, company, role, work email and your message. Our hosting provider also records standard technical logs, such as IP address and browser type, needed to serve the site securely.

How we use it

To respond to your enquiry, to follow up on conversations you have started with us, and to operate and secure the website. We do not sell your information, and we do not use it for third-party advertising.

Where it goes

Enquiries are received and stored in our business email and productivity systems, provided by established cloud vendors. We share your information only with service providers who help us run the site and our business, and only for those purposes, or where the law requires it.

How long we keep it

We keep enquiry correspondence for as long as the conversation is live and for a reasonable period afterwards, then delete it. You can ask us to delete it sooner.

Your choices

Email hello@augustclinical.ai to ask what we hold about you, to correct it, or to have it deleted. Depending on where you live, you may have additional rights under local data-protection law, and nothing in this notice limits them.

Cookies

This site does not use advertising cookies. If we introduce analytics, we will use a privacy-respecting configuration and update this notice.

Changes

If this notice changes, the date above changes with it.

HOME / TERMS

Website terms of use

These terms cover use of this website. Customer engagements are governed by separate written agreements.

LAST UPDATED · 28 AUGUST 2026

What this site is

This website describes August and its intended capabilities. Content is provided for general information. Product capabilities, timelines and availability may change as August develops, and nothing here constitutes an offer, a warranty or professional advice.

Intellectual property

The August name, wordmark, site design and content belong to August Clinical. You may read, link to and quote briefly from the site with attribution. Please do not reproduce substantial parts of it or use our branding without written permission.

Independent research

Where we cite third-party research, the findings belong to their authors and institutions, are linked to their original sources, and are not claims about August's own performance.

External links

Links to other websites are provided for convenience. We do not control those sites and are not responsible for their content or practices.

Liability

To the fullest extent permitted by law, we accept no liability for loss arising from reliance on the general information published on this website. Nothing in these terms excludes liability that cannot lawfully be excluded.

Contact

Questions about these terms: hello@augustclinical.ai.